1 / 21

Renal Tumours

Renal Tumours. Mr C Dawson MS FRCS Consultant Urologist Fitzwilliam Hospital Peterborough. Classification of Renal Tumours. Benign Renal tumours. Cysts account for 70% asymptomatic renal masses Cortical adenoma Oncocytoma Angiomyolipoma (80% associated with tuberous sclerosis).

emma-chambers
Download Presentation

Renal Tumours

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Renal Tumours • Mr C Dawson MS FRCS • Consultant Urologist • Fitzwilliam Hospital • Peterborough

  2. Classification of Renal Tumours

  3. Benign Renal tumours • Cysts account for 70% asymptomatic renal masses • Cortical adenoma • Oncocytoma • Angiomyolipoma (80% associated with tuberous sclerosis)

  4. Oncocytoma

  5. Oncocytoma

  6. Angiomyolipoma

  7. Renal cell carcinoma • 3% adult cancers • M:F 2:1 • Majority of patients diagnosed in 6th to 7th decade • Sporadic and hereditary forms • No specific causative agent detected - smoking suggested as a significant risk factor

  8. Familial RCC (1) • Only 2% of cases of RCC are familial • Patients affected at an earlier age (mean 44 yrs) • Relatives may be at risk and should be screened • Classified as • RCC alone • RCC with additional features (e.g. as with Von Hippel Lindau disease)

  9. Familial RCC (2) - Von Hippel Lindau disease • Von Hippel Lindau Disease - an autosomally-inherited, multisystem disorder characterised by; • high risk of RCC (>70% by the age of 60) • retinal and cerebellar haemangioblastomata • phaeochromocytomas • renal, pancreatic, and epididymal cyst • VHL is the most common cause of inherited RCC, and RCC is the most common cause of death in VHL

  10. Familial RCC (3) - Von Hippel Lindau disease • All patients (and relatives) should undergo screening from age 15 • Tumours >3cm should be removed to prevent metastasis • Tumours are often bilateral and/or multifocal - so kidney preserving surgery often required • Gene for VHL discovered in 1993 - acts normally as a tumour suppressor gene. Loss of both copies therefore required. • Inactivation of both VHL genes is also the crucial step in the development of most clear-cell type (non-familial) RCCs

  11. Presentation of renal cell carcinoma • Classic triad of pain, haematuria, and flank mass (rare) • More commonly just pain and haematuria • Symptoms of metastatic disease • Paraneoplastic syndromes • INCIDENTAL - discovered while investigating another problem

  12. Investigation • Ultrasound - distinguish solid from cystic mass • CT - Staging, prior to surgery • MRI - less sensitive than CT for lesions less than 3cm • Angiography - tumour in solitary kidney if partial nephrectomy considered

  13. CT Scan of Renal tumour

  14. MRI of lymph node from renal tumour

  15. Staging of renal carcinoma

  16. Staging of renal carcinoma

  17. Treatment • Radical nephrectomy remains the only effective method of treating primary renal carcinoma

  18. Tumour in a solitary kidney or bilateral tumours • Partial nephrectomy gives excellent short term results (72% tumour free survival at 3 yrs) • Survival independent of whether tumour present in other kidney • Survival dependent on stage of local tumour

  19. Treatment of metastatic disease • Generally poor prognosis • Renal cancer remains refractory to treatment with Chemotherapy • Hormonal therapy • Immunotherapy • Palliative nephrectomy

  20. Prognosis • 5 year survival • 60-82% Stage I • 47-80% Stage II • 35-51% Stage III • Survival increased by pre-op radiotherapy in some studies • Incidental tumours - 15-30% of all tumours • Better prognosis (related to stage and grade) • Significantly longer disease-free and overall survival than with symptomatic tumours

  21. Survival

More Related